Nova Eye Medical Limited (ASX:EYE)
0.1200
+0.0050 (4.35%)
Jul 17, 2026, 3:01 PM AEST
Nova Eye Medical Market Cap
Nova Eye Medical has a market cap or net worth of 34.18 million as of July 17, 2026. Its market cap has decreased by -3.77% in one year.
Market Cap
34.18M
Enterprise Value
34.35M
Revenue
33.05M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.12
ChartMarket Cap Chart
Since March 9, 1998, Nova Eye Medical's market cap has increased from 785.81K to 34.18M, an increase of 4,249.75%. That is a compound annual growth rate of 14.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 34.18M | -9.43% |
| Dec 31, 2025 | 37.74M | 2.97% |
| Dec 31, 2024 | 36.65M | -19.89% |
| Dec 29, 2023 | 45.75M | 12.00% |
| Dec 29, 2022 | 40.85M | -17.46% |
| Dec 31, 2021 | 49.49M | -2.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cleo Diagnostics | 55.43M |
| OncoSil Medical | 45.43M |
| Compumedics | 44.95M |
| HeraMED | 43.98M |
| CleanSpace Holdings | 31.56M |
| Control Bionics | 30.49M |
| Micro-X | 25.43M |
| Memphasys | 24.70M |